Clinical Immunology Service

Organisational unit: Department

41 - 50 out of 66Page size: 10

Publications

  1. 2019
  2. Published

    Bacterial flagellin promotes viral entry via an NF-kB and Toll Like Receptor 5 dependent pathway

    Dalan Bailey, Michelle MC Buckner, Jessica Blair, Timothy Wells, Margaret Goodall, Adriana Flores-Langarica, Peter Balfe, Ian Henderson, Laura Piddock, Adam Cunningham & Jane McKeating, 27 May 2019, In: Scientific Reports. 9, 1

    Research output: Contribution to journal › Article › peer-review

  3. Published

    The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial

    Dickens Pratt & Mark Drayson, May 2019, In: British Journal of Haematology. 185, 3, p. 450-467 18 p.

    Research output: Contribution to journal › Article › peer-review

  4. Published

    Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML

    Sylvie Freeman & 4 others, , 1 Apr 2019, In: The Journal of Experimental Medicine. 216, 4, p. 966-981 16 p.

    Research output: Contribution to journal › Article › peer-review

  5. Published

    Type 1 diabetes impairs the mobilisation of highly-differentiated CD8+T cells during a single bout of acute exercise

    Mark Drayson & Parth Narendran, 13 Feb 2019, In: Exercise Immunology Review. 25, p. 64-82 19 p.

    Research output: Contribution to journal › Article › peer-review

  6. Published

    Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

    Mark Drayson & 2 others, , Jan 2019, In: The Lancet Oncology. 20, 1, p. 57-73 17 p.

    Research output: Contribution to journal › Article › peer-review

  7. 2018
  8. E-pub ahead of print

    Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults

    Sylvie Freeman, 5 Dec 2018, In: British Journal of Haematology. 4 p.

    Research output: Contribution to journal › Letter › peer-review

  9. Published

    What is the significance of monoclonal gammopathy of undetermined significance?

    Catherine Atkin, Alex Richter & Elizabeth Sapey, Oct 2018, In: Clinical Medicine. 18, 5, p. 391-396 6 p.

    Research output: Contribution to journal › Review article › peer-review

  10. Published

    Role of minimal (measurable) residual disease assessment in older patients with acute myeloid leukemia

    Sylvie Freeman, 1 Jul 2018, In: Cancers. 10, 7, 15 p., 215.

    Research output: Contribution to journal › Review article › peer-review

  11. 2017
  12. Published

    The primary immunodeficiency disorders

    Adrian Shields, 1 Oct 2017, In: Medicine. 45, 10, p. 597-604

    Research output: Contribution to journal › Article › peer-review

  13. 2016
  14. Published

    Morning vaccination enhances antibody response over afternoon vaccination: a cluster-randomised trial

    Joanna Long, Mark Drayson, Angela Taylor, Kai Toellner, Janet Lord & Anna Whittaker, 23 May 2016, In: Vaccine. 34, 24, p. 2679-2685 7 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 4 5 6 7 Next